Mitral Valve

The heart's mitral valve is the site of the most surgical valve repairs and valve replacements. After the resounding success of transcatheter aortic valve replacement (TAVR), which now makes up more than 50% of aortic valve replacements, there is wide expectation transcatheter mitral replacements will follow in the next few year. Currently, the most common transcatheter mitral procedure is transcatheter edge-to-edge (TEER) , using the MitraClip or Pascal clip devices. These devices are also being used for transcatheter tricuspid valve repair (TTVR). Other transcatheter mitral repair systems are in trials for minimally invasive annuloplasty and chordae tendineae repair.

AI-powered EHR alerts make a world of difference for cardiologists, heart patients
AI can help care teams identify heart patients who would benefit from TAVR or another life-changing valve intervention.
FDA clears new AI software for mitral valve repair
Philips worked closely with Edwards Lifesciences to develop the new software.
Interventional cardiologists implant new-look heart device for first time in US
The Amend device from Valcare Medical has a closed ring shape similar to the annuloplasty rings used to treat MR during open-heart surgeries. These early patients will be followed for a total of five years.
TMVR device with valve-in-ring design gains key approval
HighLife's new-look TMVR technology was designed to treat a wide range of patients. The two-part implant process includes a ring and a valve that centers itself inside that ring.
Abbott executive who led TAVR, Tendyne divisions announces exit
Chris Waddell, a medtech executive focused on various structural heart technologies, is leaving Abbott after several years to "recharge" and pursue a new opportunity.

AI-powered EHR alerts make a world of difference for cardiologists, heart patients

AI can help care teams identify heart patients who would benefit from TAVR or another life-changing valve intervention.

Philips has secured U.S. Food and Drug Administration (FDA) clearance for EchoNavigator R5.0 with DeviceGuide, the company’s artificial intelligence (AI)-enabled software for mitral transcatheter edge-to-edge repair (M-TEER).

FDA clears new AI software for mitral valve repair

Philips worked closely with Edwards Lifesciences to develop the new software.

Valcare Medical’s Amend Transseptal System for mitral regurgitation

Interventional cardiologists implant new-look heart device for first time in US

The Amend device from Valcare Medical has a closed ring shape similar to the annuloplasty rings used to treat MR during open-heart surgeries. These early patients will be followed for a total of five years.

HighLife Transcatheter Mitral Valve Replacement (TMVR) System

TMVR device with valve-in-ring design gains key approval

HighLife's new-look TMVR technology was designed to treat a wide range of patients. The two-part implant process includes a ring and a valve that centers itself inside that ring.

Abbott executive who led TAVR, Tendyne divisions announces exit

Chris Waddell, a medtech executive focused on various structural heart technologies, is leaving Abbott after several years to "recharge" and pursue a new opportunity.

Low-volume operators linked to worse outcomes after TAVR, M-TEER

Researchers tracked data from more than 400,00 patients, sharing their findings in JAMA Cardiology.

FDA approves TMVR system from Edwards Lifesciences for high-risk heart patients

The Sapien M3 transcatheter mitral valve replacement system is implanted using a transseptal approach. The device previously received CE mark approval in 2025.

M-TEER still beneficial for high-risk patients with smaller mitral valve areas

Mitral valve surgery can be especially challenging when patients present with a small mitral valve area. When it comes to M-TEER, however, treatment still appears to be both safe and effective.